http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 31 Aug 2026 06:53:31 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Analyst+PT+Change/Brainsway+%28BWAY%29+PT+Raised+to+%2419+at+H.C.+Wainwright/27000334.html <p>H.C. Wainwright analyst Raghuram Selvaraju raised the price target on Brainsway (NASDAQ: BWAY) to $19.00 (from $17.00) while maintaining a Buy rating.</p><p>The analyst commented: "Late last week, BrainsWay reported the publication of new peer-reviewed data showing significant reductions in suicidal ideation among patients with major depressive disorder (MDD) treated with Deep Transcranial Magnetic Stimulation (Deep TMS). The publication, entitled “Effects of H-coil TMS on suicidality in major depression: A secondary analysis of data from a multi-site randomized trial comparing accelerated to once-a-day stimulation,” was published in the Journal of Affective Disorders. After factoring in our forecast revisions and the moderate http://www.streetinsider.com/Analyst+PT+Change/Brainsway+%28BWAY%29+PT+Raised+to+%2419+at+H.C.+Wainwright/27000334.html Mon, 31 Aug 2026 06:53:31 -0400 BWAY http://www.streetinsider.com/Analyst+Comments/Brainsway+%28BWAY%29+PT+Raised+to+%2419+at+H.C.+Wainwright/27000334.html <p>H.C. Wainwright analyst Raghuram Selvaraju raised the price target on Brainsway (NASDAQ: BWAY) to $19.00 (from $17.00) while maintaining a Buy rating.</p><p>The analyst commented: "Late last week, BrainsWay reported the publication of new peer-reviewed data showing significant reductions in suicidal ideation among patients with major depressive disorder (MDD) treated with Deep Transcranial Magnetic Stimulation (Deep TMS). The publication, entitled “Effects of H-coil TMS on suicidality in major depression: A secondary analysis of data from a multi-site randomized trial comparing accelerated to once-a-day stimulation,” was published in the Journal of Affective Disorders. After factoring in our forecast revisions and the moderate http://www.streetinsider.com/Analyst+Comments/Brainsway+%28BWAY%29+PT+Raised+to+%2419+at+H.C.+Wainwright/27000334.html Mon, 31 Aug 2026 06:53:31 -0400 BWAY http://www.streetinsider.com/Press+Releases/BrainsWay+Deep+TMS%E2%84%A2+Study+Shows+70%25+Reduction+in+Patients+Experiencing+Suicidal+Ideation/26984748.html <p>BURLINGTON, Mass. and JERUSALEM, Aug. 27, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ &amp; TASE: BWAY), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the publication of new peer-reviewed data demonstrating significant reductions in suicidal ideation among patients with Major Depressive Disorder (MDD) treated with Deep Transcranial Magnetic Stimulation (Deep TMS™).</p> <p>The publication, entitled “<a target="_blank" href="https://www.globenewswire.com/Tracker?data=AnH87SrXGlzg3VYucqpnQh4QrZvte4zp3xmMzg4g12EQsp1RoqUJTZbEkbqpWO450Iw_eZ9oiqdkfP7VpQyIXPqwejBBpowvg4ruX6bB-4WxmLBvAHSywJvt8OoMtOHQzeL_O0CvVP7lis2FpGHvKoXK5O_a99DqkmZk2g2Dv5B16I40PoCJjHtESUrBfFu3Go4F_mplw6W7yz4SsgiyntNmLLw9B6u6RyEj4ndK0s3H1ThvDoy5MrSfAGQKeuNnPLk8ttGCrkOmpd-Yqlr1z3JmTdSD2_5ztfbFq0vMTp2D4upiXIrj8gmC3_AfDtUimumhiRa3XQ8k787Ht1oAF2yVUpB8aAWV0WnJTUVERJ4=" rel="nofollow" target="_blank"><em>Effects of H-coil TMS on suicidality in major depression: A secondary analysis of data from a multisite randomized trial comparing accelerated to once-a-day stimulation</em></a>,” was published in the <em>Journal of Affective Disorders</em>. The http://www.streetinsider.com/Press+Releases/BrainsWay+Deep+TMS%E2%84%A2+Study+Shows+70%25+Reduction+in+Patients+Experiencing+Suicidal+Ideation/26984748.html Thu, 27 Aug 2026 07:30:00 -0400 A.02188078 BWAY BWAY O.05892621 O.39152266 http://www.streetinsider.com/Press+Releases/BrainsWay+Deep+TMS%E2%84%A2+Study+Shows+70%25+Reduction+in+Patients+Experiencing+Suicidal+Ideation/26984748.html <p>BURLINGTON, Mass. and JERUSALEM, Aug. 27, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ &amp; TASE: BWAY), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the publication of new peer-reviewed data demonstrating significant reductions in suicidal ideation among patients with Major Depressive Disorder (MDD) treated with Deep Transcranial Magnetic Stimulation (Deep TMS™).</p> <p>The publication, entitled “<a target="_blank" href="https://www.globenewswire.com/Tracker?data=AnH87SrXGlzg3VYucqpnQh4QrZvte4zp3xmMzg4g12EQsp1RoqUJTZbEkbqpWO450Iw_eZ9oiqdkfP7VpQyIXPqwejBBpowvg4ruX6bB-4WxmLBvAHSywJvt8OoMtOHQzeL_O0CvVP7lis2FpGHvKoXK5O_a99DqkmZk2g2Dv5B16I40PoCJjHtESUrBfFu3Go4F_mplw6W7yz4SsgiyntNmLLw9B6u6RyEj4ndK0s3H1ThvDoy5MrSfAGQKeuNnPLk8ttGCrkOmpd-Yqlr1z3JmTdSD2_5ztfbFq0vMTp2D4upiXIrj8gmC3_AfDtUimumhiRa3XQ8k787Ht1oAF2yVUpB8aAWV0WnJTUVERJ4=" rel="nofollow" target="_blank"><em>Effects of H-coil TMS on suicidality in major depression: A secondary analysis of data from a multisite randomized trial comparing accelerated to once-a-day stimulation</em></a>,” was published in the <em>Journal of Affective Disorders</em>. The http://www.streetinsider.com/Press+Releases/BrainsWay+Deep+TMS%E2%84%A2+Study+Shows+70%25+Reduction+in+Patients+Experiencing+Suicidal+Ideation/26984748.html Thu, 27 Aug 2026 07:30:00 -0400 A.02188078 BWAY BWAY O.05892621 O.39152266 http://www.streetinsider.com/Press+Releases/BrainsWay+Deep+TMS%E2%84%A2+Study+Shows+70%25+Reduction+in+Patients+Experiencing+Suicidal+Ideation/26984748.html <p>BURLINGTON, Mass. and JERUSALEM, Aug. 27, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ &amp; TASE: BWAY), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the publication of new peer-reviewed data demonstrating significant reductions in suicidal ideation among patients with Major Depressive Disorder (MDD) treated with Deep Transcranial Magnetic Stimulation (Deep TMS™).</p> <p>The publication, entitled “<a target="_blank" href="https://www.globenewswire.com/Tracker?data=AnH87SrXGlzg3VYucqpnQh4QrZvte4zp3xmMzg4g12EQsp1RoqUJTZbEkbqpWO450Iw_eZ9oiqdkfP7VpQyIXPqwejBBpowvg4ruX6bB-4WxmLBvAHSywJvt8OoMtOHQzeL_O0CvVP7lis2FpGHvKoXK5O_a99DqkmZk2g2Dv5B16I40PoCJjHtESUrBfFu3Go4F_mplw6W7yz4SsgiyntNmLLw9B6u6RyEj4ndK0s3H1ThvDoy5MrSfAGQKeuNnPLk8ttGCrkOmpd-Yqlr1z3JmTdSD2_5ztfbFq0vMTp2D4upiXIrj8gmC3_AfDtUimumhiRa3XQ8k787Ht1oAF2yVUpB8aAWV0WnJTUVERJ4=" rel="nofollow" target="_blank"><em>Effects of H-coil TMS on suicidality in major depression: A secondary analysis of data from a multisite randomized trial comparing accelerated to once-a-day stimulation</em></a>,” was published in the <em>Journal of Affective Disorders</em>. The http://www.streetinsider.com/Press+Releases/BrainsWay+Deep+TMS%E2%84%A2+Study+Shows+70%25+Reduction+in+Patients+Experiencing+Suicidal+Ideation/26984748.html Thu, 27 Aug 2026 07:30:00 -0400 A.02188078 BWAY BWAY O.05892621 O.39152266 http://www.streetinsider.com/Press+Releases/BrainsWay+Deep+TMS%E2%84%A2+Study+Shows+70%25+Reduction+in+Patients+Experiencing+Suicidal+Ideation/26984748.html <p>BURLINGTON, Mass. and JERUSALEM, Aug. 27, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ &amp; TASE: BWAY), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the publication of new peer-reviewed data demonstrating significant reductions in suicidal ideation among patients with Major Depressive Disorder (MDD) treated with Deep Transcranial Magnetic Stimulation (Deep TMS™).</p> <p>The publication, entitled “<a target="_blank" href="https://www.globenewswire.com/Tracker?data=AnH87SrXGlzg3VYucqpnQh4QrZvte4zp3xmMzg4g12EQsp1RoqUJTZbEkbqpWO450Iw_eZ9oiqdkfP7VpQyIXPqwejBBpowvg4ruX6bB-4WxmLBvAHSywJvt8OoMtOHQzeL_O0CvVP7lis2FpGHvKoXK5O_a99DqkmZk2g2Dv5B16I40PoCJjHtESUrBfFu3Go4F_mplw6W7yz4SsgiyntNmLLw9B6u6RyEj4ndK0s3H1ThvDoy5MrSfAGQKeuNnPLk8ttGCrkOmpd-Yqlr1z3JmTdSD2_5ztfbFq0vMTp2D4upiXIrj8gmC3_AfDtUimumhiRa3XQ8k787Ht1oAF2yVUpB8aAWV0WnJTUVERJ4=" rel="nofollow" target="_blank"><em>Effects of H-coil TMS on suicidality in major depression: A secondary analysis of data from a multisite randomized trial comparing accelerated to once-a-day stimulation</em></a>,” was published in the <em>Journal of Affective Disorders</em>. The http://www.streetinsider.com/Press+Releases/BrainsWay+Deep+TMS%E2%84%A2+Study+Shows+70%25+Reduction+in+Patients+Experiencing+Suicidal+Ideation/26984748.html Thu, 27 Aug 2026 07:30:00 -0400 A.02188078 BWAY BWAY O.05892621 O.39152266 http://www.streetinsider.com/Press+Releases/BrainsWay+Deep+TMS%E2%84%A2+Study+Shows+70%25+Reduction+in+Patients+Experiencing+Suicidal+Ideation/26984748.html <p>BURLINGTON, Mass. and JERUSALEM, Aug. 27, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ &amp; TASE: BWAY), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the publication of new peer-reviewed data demonstrating significant reductions in suicidal ideation among patients with Major Depressive Disorder (MDD) treated with Deep Transcranial Magnetic Stimulation (Deep TMS™).</p> <p>The publication, entitled “<a target="_blank" href="https://www.globenewswire.com/Tracker?data=AnH87SrXGlzg3VYucqpnQh4QrZvte4zp3xmMzg4g12EQsp1RoqUJTZbEkbqpWO450Iw_eZ9oiqdkfP7VpQyIXPqwejBBpowvg4ruX6bB-4WxmLBvAHSywJvt8OoMtOHQzeL_O0CvVP7lis2FpGHvKoXK5O_a99DqkmZk2g2Dv5B16I40PoCJjHtESUrBfFu3Go4F_mplw6W7yz4SsgiyntNmLLw9B6u6RyEj4ndK0s3H1ThvDoy5MrSfAGQKeuNnPLk8ttGCrkOmpd-Yqlr1z3JmTdSD2_5ztfbFq0vMTp2D4upiXIrj8gmC3_AfDtUimumhiRa3XQ8k787Ht1oAF2yVUpB8aAWV0WnJTUVERJ4=" rel="nofollow" target="_blank"><em>Effects of H-coil TMS on suicidality in major depression: A secondary analysis of data from a multisite randomized trial comparing accelerated to once-a-day stimulation</em></a>,” was published in the <em>Journal of Affective Disorders</em>. The http://www.streetinsider.com/Press+Releases/BrainsWay+Deep+TMS%E2%84%A2+Study+Shows+70%25+Reduction+in+Patients+Experiencing+Suicidal+Ideation/26984748.html Thu, 27 Aug 2026 07:30:00 -0400 A.02188078 BWAY BWAY O.05892621 O.39152266 http://www.streetinsider.com/Globe+Newswire/BrainsWay+Deep+TMS%E2%84%A2+Study+Shows+70%25+Reduction+in+Patients+Experiencing+Suicidal+Ideation/26984748.html <p>BURLINGTON, Mass. and JERUSALEM, Aug. 27, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ &amp; TASE: BWAY), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the publication of new peer-reviewed data demonstrating significant reductions in suicidal ideation among patients with Major Depressive Disorder (MDD) treated with Deep Transcranial Magnetic Stimulation (Deep TMS™).</p> <p>The publication, entitled “<a target="_blank" href="https://www.globenewswire.com/Tracker?data=AnH87SrXGlzg3VYucqpnQh4QrZvte4zp3xmMzg4g12EQsp1RoqUJTZbEkbqpWO450Iw_eZ9oiqdkfP7VpQyIXPqwejBBpowvg4ruX6bB-4WxmLBvAHSywJvt8OoMtOHQzeL_O0CvVP7lis2FpGHvKoXK5O_a99DqkmZk2g2Dv5B16I40PoCJjHtESUrBfFu3Go4F_mplw6W7yz4SsgiyntNmLLw9B6u6RyEj4ndK0s3H1ThvDoy5MrSfAGQKeuNnPLk8ttGCrkOmpd-Yqlr1z3JmTdSD2_5ztfbFq0vMTp2D4upiXIrj8gmC3_AfDtUimumhiRa3XQ8k787Ht1oAF2yVUpB8aAWV0WnJTUVERJ4=" rel="nofollow" target="_blank"><em>Effects of H-coil TMS on suicidality in major depression: A secondary analysis of data from a multisite randomized trial comparing accelerated to once-a-day stimulation</em></a>,” was published in the <em>Journal of Affective Disorders</em>. The http://www.streetinsider.com/Globe+Newswire/BrainsWay+Deep+TMS%E2%84%A2+Study+Shows+70%25+Reduction+in+Patients+Experiencing+Suicidal+Ideation/26984748.html Thu, 27 Aug 2026 07:30:00 -0400 A.02188078 BWAY BWAY O.05892621 O.39152266 http://www.streetinsider.com/Globe+Newswire/BrainsWay+Deep+TMS%E2%84%A2+Study+Shows+70%25+Reduction+in+Patients+Experiencing+Suicidal+Ideation/26984748.html <p>BURLINGTON, Mass. and JERUSALEM, Aug. 27, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ &amp; TASE: BWAY), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the publication of new peer-reviewed data demonstrating significant reductions in suicidal ideation among patients with Major Depressive Disorder (MDD) treated with Deep Transcranial Magnetic Stimulation (Deep TMS™).</p> <p>The publication, entitled “<a target="_blank" href="https://www.globenewswire.com/Tracker?data=AnH87SrXGlzg3VYucqpnQh4QrZvte4zp3xmMzg4g12EQsp1RoqUJTZbEkbqpWO450Iw_eZ9oiqdkfP7VpQyIXPqwejBBpowvg4ruX6bB-4WxmLBvAHSywJvt8OoMtOHQzeL_O0CvVP7lis2FpGHvKoXK5O_a99DqkmZk2g2Dv5B16I40PoCJjHtESUrBfFu3Go4F_mplw6W7yz4SsgiyntNmLLw9B6u6RyEj4ndK0s3H1ThvDoy5MrSfAGQKeuNnPLk8ttGCrkOmpd-Yqlr1z3JmTdSD2_5ztfbFq0vMTp2D4upiXIrj8gmC3_AfDtUimumhiRa3XQ8k787Ht1oAF2yVUpB8aAWV0WnJTUVERJ4=" rel="nofollow" target="_blank"><em>Effects of H-coil TMS on suicidality in major depression: A secondary analysis of data from a multisite randomized trial comparing accelerated to once-a-day stimulation</em></a>,” was published in the <em>Journal of Affective Disorders</em>. The http://www.streetinsider.com/Globe+Newswire/BrainsWay+Deep+TMS%E2%84%A2+Study+Shows+70%25+Reduction+in+Patients+Experiencing+Suicidal+Ideation/26984748.html Thu, 27 Aug 2026 07:30:00 -0400 A.02188078 BWAY BWAY O.05892621 O.39152266 http://www.streetinsider.com/Globe+Newswire/BrainsWay+Deep+TMS%E2%84%A2+Study+Shows+70%25+Reduction+in+Patients+Experiencing+Suicidal+Ideation/26984748.html <p>BURLINGTON, Mass. and JERUSALEM, Aug. 27, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ &amp; TASE: BWAY), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the publication of new peer-reviewed data demonstrating significant reductions in suicidal ideation among patients with Major Depressive Disorder (MDD) treated with Deep Transcranial Magnetic Stimulation (Deep TMS™).</p> <p>The publication, entitled “<a target="_blank" href="https://www.globenewswire.com/Tracker?data=AnH87SrXGlzg3VYucqpnQh4QrZvte4zp3xmMzg4g12EQsp1RoqUJTZbEkbqpWO450Iw_eZ9oiqdkfP7VpQyIXPqwejBBpowvg4ruX6bB-4WxmLBvAHSywJvt8OoMtOHQzeL_O0CvVP7lis2FpGHvKoXK5O_a99DqkmZk2g2Dv5B16I40PoCJjHtESUrBfFu3Go4F_mplw6W7yz4SsgiyntNmLLw9B6u6RyEj4ndK0s3H1ThvDoy5MrSfAGQKeuNnPLk8ttGCrkOmpd-Yqlr1z3JmTdSD2_5ztfbFq0vMTp2D4upiXIrj8gmC3_AfDtUimumhiRa3XQ8k787Ht1oAF2yVUpB8aAWV0WnJTUVERJ4=" rel="nofollow" target="_blank"><em>Effects of H-coil TMS on suicidality in major depression: A secondary analysis of data from a multisite randomized trial comparing accelerated to once-a-day stimulation</em></a>,” was published in the <em>Journal of Affective Disorders</em>. The http://www.streetinsider.com/Globe+Newswire/BrainsWay+Deep+TMS%E2%84%A2+Study+Shows+70%25+Reduction+in+Patients+Experiencing+Suicidal+Ideation/26984748.html Thu, 27 Aug 2026 07:30:00 -0400 A.02188078 BWAY BWAY O.05892621 O.39152266 http://www.streetinsider.com/Globe+Newswire/BrainsWay+Deep+TMS%E2%84%A2+Study+Shows+70%25+Reduction+in+Patients+Experiencing+Suicidal+Ideation/26984748.html <p>BURLINGTON, Mass. and JERUSALEM, Aug. 27, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ &amp; TASE: BWAY), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the publication of new peer-reviewed data demonstrating significant reductions in suicidal ideation among patients with Major Depressive Disorder (MDD) treated with Deep Transcranial Magnetic Stimulation (Deep TMS™).</p> <p>The publication, entitled “<a target="_blank" href="https://www.globenewswire.com/Tracker?data=AnH87SrXGlzg3VYucqpnQh4QrZvte4zp3xmMzg4g12EQsp1RoqUJTZbEkbqpWO450Iw_eZ9oiqdkfP7VpQyIXPqwejBBpowvg4ruX6bB-4WxmLBvAHSywJvt8OoMtOHQzeL_O0CvVP7lis2FpGHvKoXK5O_a99DqkmZk2g2Dv5B16I40PoCJjHtESUrBfFu3Go4F_mplw6W7yz4SsgiyntNmLLw9B6u6RyEj4ndK0s3H1ThvDoy5MrSfAGQKeuNnPLk8ttGCrkOmpd-Yqlr1z3JmTdSD2_5ztfbFq0vMTp2D4upiXIrj8gmC3_AfDtUimumhiRa3XQ8k787Ht1oAF2yVUpB8aAWV0WnJTUVERJ4=" rel="nofollow" target="_blank"><em>Effects of H-coil TMS on suicidality in major depression: A secondary analysis of data from a multisite randomized trial comparing accelerated to once-a-day stimulation</em></a>,” was published in the <em>Journal of Affective Disorders</em>. The http://www.streetinsider.com/Globe+Newswire/BrainsWay+Deep+TMS%E2%84%A2+Study+Shows+70%25+Reduction+in+Patients+Experiencing+Suicidal+Ideation/26984748.html Thu, 27 Aug 2026 07:30:00 -0400 A.02188078 BWAY BWAY O.05892621 O.39152266 http://www.streetinsider.com/Globe+Newswire/BrainsWay+Deep+TMS%E2%84%A2+Study+Shows+70%25+Reduction+in+Patients+Experiencing+Suicidal+Ideation/26984748.html <p>BURLINGTON, Mass. and JERUSALEM, Aug. 27, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ &amp; TASE: BWAY), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the publication of new peer-reviewed data demonstrating significant reductions in suicidal ideation among patients with Major Depressive Disorder (MDD) treated with Deep Transcranial Magnetic Stimulation (Deep TMS™).</p> <p>The publication, entitled “<a target="_blank" href="https://www.globenewswire.com/Tracker?data=AnH87SrXGlzg3VYucqpnQh4QrZvte4zp3xmMzg4g12EQsp1RoqUJTZbEkbqpWO450Iw_eZ9oiqdkfP7VpQyIXPqwejBBpowvg4ruX6bB-4WxmLBvAHSywJvt8OoMtOHQzeL_O0CvVP7lis2FpGHvKoXK5O_a99DqkmZk2g2Dv5B16I40PoCJjHtESUrBfFu3Go4F_mplw6W7yz4SsgiyntNmLLw9B6u6RyEj4ndK0s3H1ThvDoy5MrSfAGQKeuNnPLk8ttGCrkOmpd-Yqlr1z3JmTdSD2_5ztfbFq0vMTp2D4upiXIrj8gmC3_AfDtUimumhiRa3XQ8k787Ht1oAF2yVUpB8aAWV0WnJTUVERJ4=" rel="nofollow" target="_blank"><em>Effects of H-coil TMS on suicidality in major depression: A secondary analysis of data from a multisite randomized trial comparing accelerated to once-a-day stimulation</em></a>,” was published in the <em>Journal of Affective Disorders</em>. The http://www.streetinsider.com/Globe+Newswire/BrainsWay+Deep+TMS%E2%84%A2+Study+Shows+70%25+Reduction+in+Patients+Experiencing+Suicidal+Ideation/26984748.html Thu, 27 Aug 2026 07:30:00 -0400 A.02188078 BWAY BWAY O.05892621 O.39152266 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Brainsway+Ltd.++++++++++++For%3A+Aug+27/26984767.html si-local-file:///var/storage/secattach/20260827/26984767.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Brainsway+Ltd.++++++++++++For%3A+Aug+27/26984767.html Thu, 27 Aug 2026 07:30:00 -0400 BWAY BWAY O.05892621 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Brainsway+Ltd.++++++++++++For%3A+Aug+27/26984767.html si-local-file:///var/storage/secattach/20260827/26984767.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Brainsway+Ltd.++++++++++++For%3A+Aug+27/26984767.html Thu, 27 Aug 2026 07:30:00 -0400 BWAY BWAY O.05892621 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Brainsway+Ltd.++++++++++++For%3A+Aug+27/26984767.html si-local-file:///var/storage/secattach/20260827/26984767.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Brainsway+Ltd.++++++++++++For%3A+Aug+27/26984767.html Thu, 27 Aug 2026 07:30:00 -0400 BWAY BWAY O.05892621 http://www.streetinsider.com/Analyst+PT+Change/Brainsway+%28BWAY%29+PT+Raised+to+%2418.80+at+Ladenburg+Thalmann/26916611.html Ladenburg Thalmann analyst Jeffery Cohen raised the price target on Brainsway (NASDAQ: BWAY) to $18.80 (from $18.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Brainsway+%28BWAY%29+PT+Raised+to+%2418.80+at+Ladenburg+Thalmann/26916611.html Thu, 13 Aug 2026 07:47:18 -0400 BWAY http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Brainsway+Ltd.++++++++++++For%3A+Aug+12/26912595.html si-local-file:///var/storage/secattach/20260812/26912595.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Brainsway+Ltd.++++++++++++For%3A+Aug+12/26912595.html Wed, 12 Aug 2026 16:02:00 -0400 BWAY BWAY O.05892621 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Brainsway+Ltd.++++++++++++For%3A+Aug+12/26912595.html si-local-file:///var/storage/secattach/20260812/26912595.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Brainsway+Ltd.++++++++++++For%3A+Aug+12/26912595.html Wed, 12 Aug 2026 16:02:00 -0400 BWAY BWAY O.05892621 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Brainsway+Ltd.++++++++++++For%3A+Aug+12/26912595.html si-local-file:///var/storage/secattach/20260812/26912595.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Brainsway+Ltd.++++++++++++For%3A+Aug+12/26912595.html Wed, 12 Aug 2026 16:02:00 -0400 BWAY BWAY O.05892621 http://www.streetinsider.com/Analyst+PT+Change/Brainsway+%28BWAY%29+PT+Raised+to+%2420+at+BTIG/26911559.html (Updated - August 12, 2026 1:02 PM EDT) <p>BTIG analyst Sam Eiber raised the price target on Brainsway (NASDAQ: BWAY) to $20.00 (from $18.00) while maintaining a Buy rating.</p><p>The analyst commented: "BrainsWay continued to demonstrate strong and consistent commercial execution as the interventional psychiatry market gains momentum, posting a record second quarter with revenue growing 35% y/y to $17.1M (vs. consensus of $16.5M). Results were driven by healthy system demand, accelerating protocol adoption, and a maturing recurring revenue model, with the company shipping a record 125 Deep TMS systems (+42% y/y) and bringing the total installed base to ~1,950 units. Remaining http://www.streetinsider.com/Analyst+PT+Change/Brainsway+%28BWAY%29+PT+Raised+to+%2420+at+BTIG/26911559.html Wed, 12 Aug 2026 13:02:46 -0400 BWAY http://www.streetinsider.com/Analyst+Comments/Brainsway+%28BWAY%29+PT+Raised+to+%2420+at+BTIG/26911559.html (Updated - August 12, 2026 1:02 PM EDT) <p>BTIG analyst Sam Eiber raised the price target on Brainsway (NASDAQ: BWAY) to $20.00 (from $18.00) while maintaining a Buy rating.</p><p>The analyst commented: "BrainsWay continued to demonstrate strong and consistent commercial execution as the interventional psychiatry market gains momentum, posting a record second quarter with revenue growing 35% y/y to $17.1M (vs. consensus of $16.5M). Results were driven by healthy system demand, accelerating protocol adoption, and a maturing recurring revenue model, with the company shipping a record 125 Deep TMS systems (+42% y/y) and bringing the total installed base to ~1,950 units. Remaining http://www.streetinsider.com/Analyst+Comments/Brainsway+%28BWAY%29+PT+Raised+to+%2420+at+BTIG/26911559.html Wed, 12 Aug 2026 13:02:46 -0400 BWAY http://www.streetinsider.com/Earnings/BrainsWay+Ltd.+%28BWAY%29+Reports+In-Line+Q3+EPS%2C+Beats+on+Revenue%3B+Offers+FY26+Revenue+Guidance/26908954.html <p>BrainsWay Ltd. (NASDAQ: BWAY) reported Q3 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $17.1 million versus the consensus estimate of $16.31 million.</p><p><strong>GUIDANCE:</strong></p><p>BrainsWay Ltd. sees FY2026 revenue of $68-70 million.</p><p>For earnings history and earnings-related data on BrainsWay Ltd. (BWAY) <a href="http://www.streetinsider.com/ec_earnings.php?q=BWAY">click here</a>.</p> http://www.streetinsider.com/Earnings/BrainsWay+Ltd.+%28BWAY%29+Reports+In-Line+Q3+EPS%2C+Beats+on+Revenue%3B+Offers+FY26+Revenue+Guidance/26908954.html Wed, 12 Aug 2026 07:32:07 -0400 BWAY http://www.streetinsider.com/Guidance/BrainsWay+Ltd.+%28BWAY%29+Reports+In-Line+Q3+EPS%2C+Beats+on+Revenue%3B+Offers+FY26+Revenue+Guidance/26908954.html <p>BrainsWay Ltd. (NASDAQ: BWAY) reported Q3 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $17.1 million versus the consensus estimate of $16.31 million.</p><p><strong>GUIDANCE:</strong></p><p>BrainsWay Ltd. sees FY2026 revenue of $68-70 million.</p><p>For earnings history and earnings-related data on BrainsWay Ltd. (BWAY) <a href="http://www.streetinsider.com/ec_earnings.php?q=BWAY">click here</a>.</p> http://www.streetinsider.com/Guidance/BrainsWay+Ltd.+%28BWAY%29+Reports+In-Line+Q3+EPS%2C+Beats+on+Revenue%3B+Offers+FY26+Revenue+Guidance/26908954.html Wed, 12 Aug 2026 07:32:07 -0400 BWAY http://www.streetinsider.com/Press+Releases/BrainsWay+Reports+Second+Quarter+2026+Financial+Results+and+Operational+Highlights/26908927.html <p align="center"><em>Record </em><em>s</em><em>econd </em><em>q</em><em>uarter 2026 </em><em>r</em><em>evenue</em><em> increased</em> <em>35%</em><em> t</em><em>o $17.</em><em>1 </em><em>m</em><em>illion, </em><em>compared with</em> <em>Q2 2025</em></p> <p align="center"><em>Adjusted EBITDA more than doubled year-over-year to $3.5 million, with margin expanding to 20%</em></p> <p align="center"><em>Remaining performance obligations grew </em><em>30</em><em>% year-over-year to $80</em><em>.4</em><em> million</em></p> <p align="center"><em>Shipped a record total 125 Deep TMS </em><em>s</em><em>ystems</em><em> in Q2 2026</em><em>, a 42% increase year-over-year</em></p> <p align="center"><em>Raises FY 2026 </em><em>r</em><em>evenue and EBITDA </em><em>g</em><em>uidance</em></p> <p>BURLINGTON, Mass. and JERUSALEM, Aug. 12, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ &amp; TASE: BWAY) (“BrainsWay” or the “Company”), http://www.streetinsider.com/Press+Releases/BrainsWay+Reports+Second+Quarter+2026+Financial+Results+and+Operational+Highlights/26908927.html Wed, 12 Aug 2026 07:30:00 -0400 A.02188078 A.50216777 BWAY BWAY O.05892621 O.39152266 O.54516537 http://www.streetinsider.com/Press+Releases/BrainsWay+Reports+Second+Quarter+2026+Financial+Results+and+Operational+Highlights/26908927.html <p align="center"><em>Record </em><em>s</em><em>econd </em><em>q</em><em>uarter 2026 </em><em>r</em><em>evenue</em><em> increased</em> <em>35%</em><em> t</em><em>o $17.</em><em>1 </em><em>m</em><em>illion, </em><em>compared with</em> <em>Q2 2025</em></p> <p align="center"><em>Adjusted EBITDA more than doubled year-over-year to $3.5 million, with margin expanding to 20%</em></p> <p align="center"><em>Remaining performance obligations grew </em><em>30</em><em>% year-over-year to $80</em><em>.4</em><em> million</em></p> <p align="center"><em>Shipped a record total 125 Deep TMS </em><em>s</em><em>ystems</em><em> in Q2 2026</em><em>, a 42% increase year-over-year</em></p> <p align="center"><em>Raises FY 2026 </em><em>r</em><em>evenue and EBITDA </em><em>g</em><em>uidance</em></p> <p>BURLINGTON, Mass. and JERUSALEM, Aug. 12, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ &amp; TASE: BWAY) (“BrainsWay” or the “Company”), http://www.streetinsider.com/Press+Releases/BrainsWay+Reports+Second+Quarter+2026+Financial+Results+and+Operational+Highlights/26908927.html Wed, 12 Aug 2026 07:30:00 -0400 A.02188078 A.50216777 BWAY BWAY O.05892621 O.39152266 O.54516537